Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A medulloblastoma that is characterized as a molecular subtype by activation of the WNT pathway and TP53 mutations may be present or absent.
Biomarker and diagnostic research for medulloblastoma WNT activated has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Pipeline includes 1 NA.
30 publications have been identified in PubMed for medulloblastoma WNT activated. Research spans Basic Science / Preclinical (30%), Epidemiology / Natural History (20%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 9 | 30% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:49 AM UTC
6 |
20% |
Testing and diagnosis research | 5 | 17% |
Research summaries | 5 | 17% |
Patient case studies | 3 | 10% |
New treatment approaches | 2 | 7% |
Peterson K (2026). [PMID: 42031704](https://pubmed.ncbi.nlm.nih.gov/42031704/). *Cell Death Dis*. [Basic Science / Preclinical]
Zhou H (2026). [PMID: 41213462](https://pubmed.ncbi.nlm.nih.gov/41213462/). *Cancer letters*. [Epidemiology / Natural History]
Comer C (2026). [PMID: 41923098](https://pubmed.ncbi.nlm.nih.gov/41923098/). *Biology direct*. [Basic Science / Preclinical]
Cigdem Karatayli E (2026). [PMID: 41710837](https://pubmed.ncbi.nlm.nih.gov/41710837/). *Cureus*. [Case Report / Case Series]
Tekin MF (2026). [PMID: 41521603](https://pubmed.ncbi.nlm.nih.gov/41521603/). *Balkan medical journal*. [Epidemiology / Natural History]
Nakano Y (2026). [PMID: 42033459](https://pubmed.ncbi.nlm.nih.gov/42033459/). *Cancer Sci*. [Epidemiology / Natural History]
Bayanova M (2026). [PMID: 41975799](https://pubmed.ncbi.nlm.nih.gov/41975799/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Ruggiero A (2026). [PMID: 41899451](https://pubmed.ncbi.nlm.nih.gov/41899451/). *Current issues in molecular biology*. [Review / Meta-Analysis]
Harry JL (2025). [PMID: 40056547](https://pubmed.ncbi.nlm.nih.gov/40056547/). *Annals of diagnostic pathology*. [Diagnostic / Biomarker]
Stefani MA (2025). [PMID: 38976175](https://pubmed.ncbi.nlm.nih.gov/38976175/). *Purinergic signalling*. [Basic Science / Preclinical]